Daniel Guthrie

This profile gathers the share dealings of Daniel Guthrie in Neuronetics, Inc. In total, 9 filings cover trades dated from 2 July 2018 to 22 May 2020.

The open-market side counts 3 purchases for €42k alongside 1 sale for €48k. Sales outweigh purchases by €5,905. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants. In 2020 alone, the filings show 1 purchase and no sales.

The median purchase comes to €10k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -2.6%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 26 May 2020 with a share grant (€4,738) in Neuronetics, Inc. The last purchase on record was published on 13 March 2020, which is 2,432 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.